Cargando…

Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare

IMPORTANCE: Older adults in Medicare Advantage (MA) enroll in hospice at higher rates than those in traditional Medicare (TM), but it is unclear whether the pathway of care prior to hospice use differs between MA and TM. OBJECTIVE: To examine the site of care prior to hospice enrollment for MA benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankuda, Claire K., Belanger, Emmanuelle, Bunker, Jennifer, Gozalo, Pedro, Keohane, Laura, Meyers, David, Trivedi, Amal, Teno, Joan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938424/
https://www.ncbi.nlm.nih.gov/pubmed/36800194
http://dx.doi.org/10.1001/jamahealthforum.2022.5457
_version_ 1784890627414032384
author Ankuda, Claire K.
Belanger, Emmanuelle
Bunker, Jennifer
Gozalo, Pedro
Keohane, Laura
Meyers, David
Trivedi, Amal
Teno, Joan M.
author_facet Ankuda, Claire K.
Belanger, Emmanuelle
Bunker, Jennifer
Gozalo, Pedro
Keohane, Laura
Meyers, David
Trivedi, Amal
Teno, Joan M.
author_sort Ankuda, Claire K.
collection PubMed
description IMPORTANCE: Older adults in Medicare Advantage (MA) enroll in hospice at higher rates than those in traditional Medicare (TM), but it is unclear whether the pathway of care prior to hospice use differs between MA and TM. OBJECTIVE: To examine the site of care prior to hospice enrollment for MA beneficiaries compared with those in TM. DESIGN, SETTING, AND PARTICIPANTS: This population-based, retrospective cross-sectional study used Medicare claims data for decedents in calendar years 2011, 2013, 2016, and 2018 who enrolled in hospice in the last 90 days of life. Data were analyzed from February 11, 2022, to October 24, 2022. EXPOSURES: Enrollment in MA or TM in the last month of life. MAIN OUTCOMES AND MEASURES: The main outcome was the site of care prior to hospice enrollment, defined as hospital, nursing home, and home with or without home health, dichotomized as community vs hospital in a logistic regression model. Covariates included decedent demographics, hospice primary diagnosis, and county-level MA penetration. Differences in hospice length of stay between MA beneficiaries and TM beneficiaries were assessed using linear and logistic regression models. RESULTS: In this study of 3 164 959 decedents, mean (SD) age was 83.1 (8.6) years, 55.8% were female, and 28.8% were enrolled in MA. Decedents in MA were more likely to enroll in hospice from a community setting than were those in TM, although the gap narrowed over time from an unadjusted 11.1% higher rate of community enrollment in MA vs TM in 2011 (50.1% vs 39.0%) to 8.1% in 2018 (46.4% vs 38.3%). In the primary adjusted analysis over the entire study period, MA enrollment was associated with an 8.09–percentage point (95% CI, 7.96-8.21 percentage points) higher rate of hospice enrollment from the community vs all other sites. This association remained in multiple sensitivity analyses to account for potential differences in the populations enrolled in MA vs TM. The mean overall hospice length of stay was 0.29 days (95% CI, 0.24-0.34 days) longer for MA decedents compared with TM decedents. CONCLUSIONS AND RELEVANCE: Compared with TM beneficiaries, those in MA were more likely to enroll in hospice from community settings vs following inpatient stays. However, hospice length of stay was not substantially different between MA and TM. Further research is needed to understand how MA plans influence hospice use and the direct association with quality of end-of-life care as reported by older adults and their families.
format Online
Article
Text
id pubmed-9938424
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-99384242023-02-19 Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare Ankuda, Claire K. Belanger, Emmanuelle Bunker, Jennifer Gozalo, Pedro Keohane, Laura Meyers, David Trivedi, Amal Teno, Joan M. JAMA Health Forum Original Investigation IMPORTANCE: Older adults in Medicare Advantage (MA) enroll in hospice at higher rates than those in traditional Medicare (TM), but it is unclear whether the pathway of care prior to hospice use differs between MA and TM. OBJECTIVE: To examine the site of care prior to hospice enrollment for MA beneficiaries compared with those in TM. DESIGN, SETTING, AND PARTICIPANTS: This population-based, retrospective cross-sectional study used Medicare claims data for decedents in calendar years 2011, 2013, 2016, and 2018 who enrolled in hospice in the last 90 days of life. Data were analyzed from February 11, 2022, to October 24, 2022. EXPOSURES: Enrollment in MA or TM in the last month of life. MAIN OUTCOMES AND MEASURES: The main outcome was the site of care prior to hospice enrollment, defined as hospital, nursing home, and home with or without home health, dichotomized as community vs hospital in a logistic regression model. Covariates included decedent demographics, hospice primary diagnosis, and county-level MA penetration. Differences in hospice length of stay between MA beneficiaries and TM beneficiaries were assessed using linear and logistic regression models. RESULTS: In this study of 3 164 959 decedents, mean (SD) age was 83.1 (8.6) years, 55.8% were female, and 28.8% were enrolled in MA. Decedents in MA were more likely to enroll in hospice from a community setting than were those in TM, although the gap narrowed over time from an unadjusted 11.1% higher rate of community enrollment in MA vs TM in 2011 (50.1% vs 39.0%) to 8.1% in 2018 (46.4% vs 38.3%). In the primary adjusted analysis over the entire study period, MA enrollment was associated with an 8.09–percentage point (95% CI, 7.96-8.21 percentage points) higher rate of hospice enrollment from the community vs all other sites. This association remained in multiple sensitivity analyses to account for potential differences in the populations enrolled in MA vs TM. The mean overall hospice length of stay was 0.29 days (95% CI, 0.24-0.34 days) longer for MA decedents compared with TM decedents. CONCLUSIONS AND RELEVANCE: Compared with TM beneficiaries, those in MA were more likely to enroll in hospice from community settings vs following inpatient stays. However, hospice length of stay was not substantially different between MA and TM. Further research is needed to understand how MA plans influence hospice use and the direct association with quality of end-of-life care as reported by older adults and their families. American Medical Association 2023-02-17 /pmc/articles/PMC9938424/ /pubmed/36800194 http://dx.doi.org/10.1001/jamahealthforum.2022.5457 Text en Copyright 2023 Ankuda CK et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Ankuda, Claire K.
Belanger, Emmanuelle
Bunker, Jennifer
Gozalo, Pedro
Keohane, Laura
Meyers, David
Trivedi, Amal
Teno, Joan M.
Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
title Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
title_full Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
title_fullStr Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
title_full_unstemmed Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
title_short Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
title_sort comparison of the pathway to hospice enrollment between medicare advantage and traditional medicare
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938424/
https://www.ncbi.nlm.nih.gov/pubmed/36800194
http://dx.doi.org/10.1001/jamahealthforum.2022.5457
work_keys_str_mv AT ankudaclairek comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT belangeremmanuelle comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT bunkerjennifer comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT gozalopedro comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT keohanelaura comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT meyersdavid comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT trivediamal comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare
AT tenojoanm comparisonofthepathwaytohospiceenrollmentbetweenmedicareadvantageandtraditionalmedicare